SCHEMBL6417845

SCHEMBL6417845

[CH2]CC(=O)N1CCC(C)CC1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.64
NPC1 O15118 4/20 0.64
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
PHGDH O43175 1/20 0.47
MGLL Q99685 1/20 0.47
HPGD P15428 4/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
ACHE P22303 1/20 0.43
HSD17B10 Q99714 1/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14417848 0.81 NPC1 (0.74) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL4164572 0.80 ALDH1A1 (0.41) ALDH1A1NPC1KMT2AMEN1HPGD
SCHEMBL10282539 0.80 ALDH1A1 (0.67) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL2606048 0.80 ALDH1A1 (0.67) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL1120405 0.78 ALDH1A1 (0.64) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL5820296 0.78 ALDH1A1 (0.64) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL8284598 0.78 ALDH1A1 (0.64) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL5803887 0.78 ALDH1A1 (0.64) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL13663831 0.78 ALDH1A1 (0.64) ALDH1A1NPC1KMT2AMEN1PHGDH
SCHEMBL229527 0.78 ALDH1A1 (1.00) ALDH1A1NPC1KMT2AMEN1PHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US claimed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO claimed
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis CASP3, BAX, BAD ALDH1A1 1368/4885NPC1 1504/4885KMT2A 3478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.